[Federal Register Volume 63, Number 188 (Tuesday, September 29, 1998)]
[Notices]
[Page 51955]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-26048]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Inter Company Collaboration for Aids Drug 
Development

    Notice is hereby given that, on July 13, 1998, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Inter Company Collaboration for 
Aids Drug Development has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership status. The notifications were filed for the 
purpose of extending the Act's provisions limiting the recovery of 
antitrust plaintiffs to actual damages under specified circumstances. 
Specifically, Trimeris, Inc., Durham, NC has been added as a party to 
this venture. Also, Hoechst AG/Hoechst Marion Roussel has been dropped 
as a party to this venture. In addition, the Dupont Merck 
Pharmaceutical Company has changed its name to Dupont Pharmaceuticals 
Company.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Inter Company Collaboration for Aids 
Drug Development intends to file additional written notification 
disclosing all changes in membership.
    On May 27, 1993, Inter Company Collaboration for Aids Drug 
Development filed its original notification pursuant to Section 6(a) of 
the Act. The Department of Justice published a notice in the Federal 
Register pursuant to Section 6(b) of the Act on July 6, 1993 (58 FR 
36223).
    The last notification was filed with the Department on September 
15, 1997. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on October 31, 1997 (62 FR 58982).
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 98-26048 Filed 9-28-98; 8:45 am]
BILLING CODE 4410-11-M